Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Asthma control and bronchodilator response.

Heffler E, Crimi N.

Respir Med. 2016 Jul;116:109. doi: 10.1016/j.rmed.2016.05.013. Epub 2016 May 15. No abstract available.

PMID:
27211114
2.

The management of asthma in the phenotype and biomarker era: The proposal of a new diagnostic-therapeutic model.

Blasi F, Bettoncelli G, Canonica GW, Centanni S, Crimi N, DiMaria G, Gasparini S, Gentili G, Girbino G, Mereu C, Minghetti P, Nardini S, Paggiaro P, Papi A, Pistolesi M, Rossi A.

J Asthma. 2016 Apr 6:1-3. [Epub ahead of print]

PMID:
27050723
3.

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ; AUSTRI Investigators.

N Engl J Med. 2016 May 12;374(19):1822-30. doi: 10.1056/NEJMoa1511049. Epub 2016 Mar 6.

4.

Depression, body mass index, and chronic obstructive pulmonary disease - a holistic approach.

Catalfo G, Crea L, Lo Castro T, Magnano San Lio F, Minutolo G, Siscaro G, Vaccino N, Crimi N, Aguglia E.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 4;11:239-49. doi: 10.2147/COPD.S84347. eCollection 2016.

5.

Bronchodilator response as a marker of poor asthma control.

Heffler E, Crimi C, Campisi R, Sichili S, Nicolosi G, Porto M, Intravaia R, Sberna ME, Liuzzo MT, Crimi N.

Respir Med. 2016 Mar;112:45-50. doi: 10.1016/j.rmed.2016.01.012. Epub 2016 Jan 22.

PMID:
26823211
6.

High prevalence of Anisakis simplex hypersensitivity and allergy in Sicily, Italy.

Heffler E, Sberna ME, Sichili S, Intravaia R, Nicolosi G, Porto M, Liuzzo MT, Picardi G, Fichera S, Crimi N.

Ann Allergy Asthma Immunol. 2016 Feb;116(2):146-50. doi: 10.1016/j.anai.2015.12.014.

PMID:
26815707
7.

Omalizumab Treatment of Vernal Keratoconjunctivitis.

Heffler E, Picardi G, Liuzzo MT, Pistorio MP, Crimi N.

JAMA Ophthalmol. 2016 Apr 1;134(4):461-3. doi: 10.1001/jamaophthalmol.2015.5679. No abstract available.

PMID:
26795360
8.

A Bloody Mess: An Unusual Case of Diffuse Alveolar Hemorrhage Because of Warfarin Overdose.

Heffler E, Campisi R, Ferri S, Crimi N.

Am J Ther. 2015 Dec 9. [Epub ahead of print]

PMID:
26658807
9.

Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC).

Heffler E, Landi M, Quadrino S, Incorvaia C, Pizzimenti S, Vernero S, Crimi N, Rolla G, Canonica GW.

Clin Mol Allergy. 2015 Nov 20;13:28. doi: 10.1186/s12948-015-0034-8. eCollection 2015.

10.

Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.

Verduri A, Luppi F, D'Amico R, Balduzzi S, Vicini R, Liverani A, Ruggieri V, Plebani M, Barbaro MP, Spanevello A, Canonica GW, Papi A, Fabbri LM, Beghè B; FARM58J2XH Study Group.

PLoS One. 2015 Mar 11;10(3):e0118241. doi: 10.1371/journal.pone.0118241. eCollection 2015.

11.

In vitro antiproliferative effect of trastuzumab (Herceptin(®)) combined with cetuximab (Erbitux(®)) in a model of human non-small cell lung cancer expressing EGFR and HER2.

Privitera G, Luca T, Musso N, Vancheri C, Crimi N, Barresi V, Condorelli D, Castorina S.

Clin Exp Med. 2016 May;16(2):161-8. doi: 10.1007/s10238-015-0343-8. Epub 2015 Feb 26.

PMID:
25716471
12.

A survey of clinical features of allergic rhinitis in adults.

Frati F, Dell'Albani I, Passalacqua G, Bonini S, Rossi O, Senna G, Incorvaia C; Adult SURF Study Group.

Med Sci Monit. 2014 Nov 4;20:2151-6. doi: 10.12659/MSM.891206.

13.

PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition.

Conte E, Gili E, Fruciano M, Korfei M, Fagone E, Iemmolo M, Lo Furno D, Giuffrida R, Crimi N, Guenther A, Vancheri C.

Lab Invest. 2013 May;93(5):566-76. doi: 10.1038/labinvest.2013.6. Epub 2013 Feb 25.

14.

Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.

Conte E, Genovese T, Gili E, Esposito E, Iemmolo M, Fruciano M, Fagone E, Pistorio MP, Crimi N, Cuzzocrea S, Vancheri C.

Eur J Clin Invest. 2013 Mar;43(3):309-15. doi: 10.1111/eci.12048. Epub 2013 Jan 16.

PMID:
23320620
15.

Protective effects of thymosin β4 in a mouse model of lung fibrosis.

Conte E, Genovese T, Gili E, Esposito E, Iemmolo M, Fruciano M, Fagone E, Pistorio MP, Crimi N, Cuzzocrea S, Vancheri C.

Ann N Y Acad Sci. 2012 Oct;1269:69-73. doi: 10.1111/j.1749-6632.2012.06694.x.

PMID:
23045972
16.

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial.

Papi A, Nicolini G, Crimi N, Fabbri L, Olivieri D, Rossi A, Paggiaro P.

Respir Res. 2012 Jun 25;13:54. doi: 10.1186/1465-9921-13-54.

17.

Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms.

Conte E, Fruciano M, Fagone E, Gili E, Caraci F, Iemmolo M, Crimi N, Vancheri C.

PLoS One. 2011;6(10):e24663. doi: 10.1371/journal.pone.0024663. Epub 2011 Oct 3.

18.

Resveratrol inhibits transforming growth factor-β-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration.

Fagone E, Conte E, Gili E, Fruciano M, Pistorio MP, Lo Furno D, Giuffrida R, Crimi N, Vancheri C.

Exp Lung Res. 2011 Apr;37(3):162-74. doi: 10.3109/01902148.2010.524722. Epub 2011 Jan 26.

PMID:
21269063
19.

Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction.

Mastruzzo C, Contrafatto MR, Crimi C, Palermo F, Vancheri C, Crimi N.

Respir Med. 2010 Oct;104(10):1417-24. doi: 10.1016/j.rmed.2010.04.014. Epub 2010 May 14.

20.

Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology.

Vancheri C, Failla M, Crimi N, Raghu G.

Eur Respir J. 2010 Mar;35(3):496-504. doi: 10.1183/09031936.00077309.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk